Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Philippidis

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Human Gene Therapy|April 18, 2020
One Small Dose, One Giant Leap for CRISPR Gene EditingAlex Philippidis
Human Gene Therapy|March 2, 2026
Lilly, Seamless Ink Up-to-$1.12B Hearing Loss CollaborationAlex Philippidis
Human Gene Therapy|August 22, 2025
Sarepta Pauses, then Resumes, Shipments of DMD Gene TherapyAlex Philippidis
Human Gene Therapy|February 16, 2023
Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell DiseaseAlex Philippidis
Human Gene Therapy|July 28, 2020
Pfizer and Sangamo Hemophilia A Gene Therapy Aces First Clinical TestAlex Philippidis
Human Gene Therapy|October 18, 2021
Fourth Boy Dies in Clinical Trial of Astellas' AT132Alex Philippidis
Human Gene Therapy|May 23, 2023
CRISPR Therapeutics, Vertex Complete Rolling Biologics License Applications for Exa-Cel in Sickle Cell Disease, Beta ThalassemiaAlex Philippidis
Human Gene Therapy|October 24, 2012
Gene therapy briefsAlex Philippidis
The CRISPR Journal|October 22, 2024
Five Years of Progress in CRISPR Clinical Trials (2019-2024)Kevin Davies, Alex Philippidis, Rodolphe Barrangou
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Human Gene Therapy|April 18, 2020
One Small Dose, One Giant Leap for CRISPR Gene EditingAlex Philippidis
Human Gene Therapy|March 2, 2026
Lilly, Seamless Ink Up-to-$1.12B Hearing Loss CollaborationAlex Philippidis
Human Gene Therapy|August 22, 2025
Sarepta Pauses, then Resumes, Shipments of DMD Gene TherapyAlex Philippidis
Human Gene Therapy|February 16, 2023
Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell DiseaseAlex Philippidis
Human Gene Therapy|July 28, 2020
Pfizer and Sangamo Hemophilia A Gene Therapy Aces First Clinical TestAlex Philippidis
Human Gene Therapy|October 18, 2021
Fourth Boy Dies in Clinical Trial of Astellas' AT132Alex Philippidis
Human Gene Therapy|May 23, 2023
CRISPR Therapeutics, Vertex Complete Rolling Biologics License Applications for Exa-Cel in Sickle Cell Disease, Beta ThalassemiaAlex Philippidis
Human Gene Therapy|October 24, 2012
Gene therapy briefsAlex Philippidis
The CRISPR Journal|October 22, 2024
Five Years of Progress in CRISPR Clinical Trials (2019-2024)Kevin Davies, Alex Philippidis, Rodolphe Barrangou
Pageof 11